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Background: Apolipoprotein A1 (ApoA1) is the major apoprotein constituent of high density lipoprotein (HDL)
which exerts innate protective effects in systemic inflammation. However, its role in the acute lung injury (ALI) has
not been well studied. In the present study we investigated the association between polymorphisms of ApoA1
gene and ALI in a Chinese population.
Methods: Three polymorphisms of the ApoA1 gene (rs11216153, rs2070665, and rs632153) were genotyped
by TaqMan method in 290 patients with sepsis-associated ALI, 285 patients sepsis alone and 330 age- and
sex-matched healthy controls.
Results: We found rs11216153 polymorphism of ApoA1 was associated with ALI, the GG genotype and G allele
was common in the ALI patients (76.9%, 88.1%, respectively) than both in the control subjects (55.8%, 75.8%,
respectively) and in the sepsis alone patients (58.2%, 78.4%, respectively). Haplotype consisting of these three SNPs
strengthened the association with ALI susceptibility. The frequency of haplotype GTG in the ALI samples was
significantly higher than that in the healthy control group (OR = 2.261, 95% CI: 1.735 ~ 2.946, P <0.001) and the
sepsis alone group (OR = 1.789, 95% CI: 1.373 ~ 2.331.P < 0.001). Carriers of the haplotype TTG had a lower risk for
ALI compared with healthy control group (OR = 0.422, 95% CI: 0.310 ~ 0.574, P < 0.001) and sepsis alone group
(OR = 0.491, 95% CI: 0.356 ~ 0.676, P <0.001).
Conclusions: These results indicated that genetic variants in the ApoA1 gene might be associated with
susceptibility to sepsis-associated ALI in Han Chinese population.
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Acute lung injury (ALI) and its more severe form, the
acute respiratory distress syndrome (ARDS), are syn-
dromes of acute respiratory failure that are characterized
by acute pulmonary edema and lung inflammation. ALI
remains an important cause of death in the intensive
care units (ICU) and few specific therapies are available
[1]. Although sepsis, pneumonia, aspiration, trauma,
pancreatitis and multiple transfusion are recognized as
the most common causes of ALI, only a small fraction
of patients with these risk factors develop ALI [2]. Clin-
ical and epidemiological studies have supported the hy-
pothesis that genetic factors might play a part in the
development and outcome of ALI [3-10]. Identification* Correspondence: hexiandi37@yeah.net
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unless otherwise stated.of genetic variants may provide new insight into the mo-
lecular pathogenesis of ALI and lead to the development
of new diagnostic and therapeutic targets [6]. The patho-
genetic basis of ALI is incompletely understood.
However, emerging evidence has suggested that the se-
verity and outcome of ALI depend significantly on sys-
temic inflammatory response [11]. Apolipoprotein A1
(ApoA1) is the major apoprotein constituent of high
density lipoprotein (HDL) which exerts innate protective
effects in systemic inflammation [12]. However, its role
in the acute lung injury (ALI) has not been well studied.
Previous study [13] suggested that one variant residing
in the ApoA1 gene, which involves a guanine to adenine
transition 75 base pairs (bp) upstream from the start of
transcription (G–75A) and destroys a site for the MspI
restriction enzyme, was associated with ALI after cardio-
pulmonary bypass surgery. In their study, the authors onlyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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to perform a case–control study. And this is a hospital
based case–control study, the selection bias cannot be
avoidable and the subjects may not be representative of
the general population.
In the present study, we established haplotypes of
ApoA1 gene consisting of 3 SNPs (rs11216153, rs2070665,
and rs632153) and to assess the relationship between
these haplotypes and ALI in a Chinese population.
Material and methods
Patients
The present study was reviewed and approved by the
Ethics Study Board of First Affiliated Hospital of Bengbu
Medical College. Informed written consent was obtained
from all subjects or from their legal surrogates before
enrollment. Definitions of sepsis and ALI were in ac-
cordance with the American College of Chest Physicians/
Society of Critical Care Medicine Consensus Conference
[14] and the American-European Consensus Conference
statements (AECC) [15].
All sepsis subjects enrolled had either severe sepsis or
septic shock. All patients were selected from the Emer-
gency and Respiratory ICUs at First Affiliated Hospital
of Bengbu Medical College, and were treated according
to the Surviving Sepsis Campaign guidelines [16]. Exclu-
sion criteria included age below 18 years, severe chronicFigure 1 Genetic variation at human ApoA1 gene. Using the Haploview
genotyped single-nucleotide polymorphisms (SNPs) in Chinese Han. Linkag
derived by solid spline method in Haploview 4.2. LD value shown: (A) |D’| × 1
red; (B) r 2 × 100; r 2 colour scheme: r 2 = 0: white; 0 < r 2 < 1: shades of grey; rrespiratory disease, severe chronic liver disease (defined
as a Child-Pugh score of > 10), using of high-dose im-
munosuppressive therapy and AIDS patients. All sepsis
patients were screened daily for ALI/ARDS development
and those who fulfilled the AECC criteria for ALI/ARDS
were considered as ALI cases, which included ALI and
ARDS patients; whereas those patients who did not de-
velop ALI/ARDS during hospital stay were considered
as sepsis alone patients. Baseline characteristics of all
patients were obtained during ICU stay. Sex- and age-
matched controls were selected from healthy blood do-
nors. We selected the control subjects aged 55–66 years,
which was matched to the patients group. There are not
significant difference between the control subjects and the
ALI patients in age and in sex.
Questionnaires including smoking, chronic illness and
the history of ALI or sepsis were obtained from all con-
trol subjects. Healthy controls were defined as indi-
viduals without any recent acute illness, any chronic
illness and a history of ALI or sepsis. To reduce the
potential confounding from ethnic backgrounds, we only
enrolled people with self-reported origin of central Han
Chinese.
Genotyping
There are 156 SNPs for the human ApoA1 gene listed in
the National Center for Biotechnology Information SNP4.2 software and the HapMap phrase II database, we scanned 5
e disequilibrium (LD) blocks across the locus in Chinese Han. LD block
00; |D’| colour scheme: |D’| =0: white; 0 < |D’| < 1: shades of pink; |D’| =1:
2 = 1: black.
Table 1 Demographic and clinical characteristics of subjects
Healthy controls ALI patients Sepsis alone patients P value
Number 330 290 285 N.A
Age, year 65.3 ± 10.2 63.8 ± 11.9 64.1 ± 10.7 0.643
Male (%) 186 (56.4) 172 (59.3) 170 (59.6) 0.877
BMI (kg.m−2) 21.1 ± 4.4 23.3 ± 4.8 23.1 ± 5.8 0.452
Diabetes (%) 0 56 (19.3) 51 (17.9) 0.078
Liver cirrhosis (%) 0 16 (5.5) 13 (4.6) 0.176
Smoker (%) 118 (34.2) 107 (36.9) 102 (35.8) 0.223
Sepsis insult (%)
Lung (%) N.A 265 (91.4) 262 (91.9) 0.989
Abdomen (%) N.A 7 (2.4) 8 (2.8) 0.997
UTI (%) N.A 5 (1.7) 4 (1.4) 0.879
Bloodstream (%) N.A 11 (3.8) 10 (3.5) 0.987
Other (%) N.A 2 (0.7) 1 (0.4) 0.774
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in Figure 1, using the Haploview 4.2 software and the
HapMap phrase II database, we obtained three tag-
ging SNPs (rs11216153, rs2070665, and rs632153) for
Chinese Han using minor allele frequency (MAF) ≥0.05
and linkage disequilibrium patterns with r 2 ≥ 0.6 as a
cutoff.
Genomic DNA was extracted from the peripheral blood
leukocytes using a DNA extraction Kit (Beijing Bioteke
Co. Ltd). Genotyping was confirmed by TaqMan method
as described previously [17].Table 2 Genotype distribution of ApoAI tag SNPs between ca
SNPs Genotype and allele Control (n = 330) ALI patien
rs11216153 GG 184 (0.558) 223 (0.769)
GT 132 (0.400) 65 (0.224)
TT 14 (0.042) 2 (0.007)
G 0.758 0.881
T 0.242 0.119
rs2070665 CC 101 (0.306) 80 (0.276)
CT 181 (0.548) 161 (0.555)
TT 48 (0.146) 49 (0.169)
C 0.580 0.553
T 0.420 0.447
rs632153 GG 281 (0.851) 246 (0.848)
GT 47 (0.142) 43 (0.148)
TT 2 (0.007) 1 (0.004)
G 0.923 0.922
T 0.077 0.078
Pa : ALI vs. control; Pb : ALI vs. Sepsis alone patients.Statistical analysis
The SPSS 17.0 for windows was used for the statistical
analysis. For each polymorphism, Hardy-Weinberg equi-
librium was assessed using the standard χ2 test or Fisher’s
exact test. Genotype frequencies in cases and controls
were compared by χ2 tests. The genotype-specific risks
were estimated as odds ratios (ORs) and it’s 95% CI.
Based on the genotype data of the genetic variations,
we performed linkage disequilibrium (LD) analysis and
haplotype-based case–control analysis, using the SHEsis
software (http://analysis2.bio-x.cn/myAnalysis.php) [18,19].se and control subjects
ts (n = 290) Sepsis alone patients (n = 285) Pa Pb















Table 3 Distribution of haplotypes (ALI patients vs.
healthy control)
Haplotype ALI patients Control P OR (95% CI)
G C G 276.00 (0.476) 332.00 (0.503) 0.339 0.897 [0.717 ~ 1.121]
G C T 45.00 (0.078) 51.00 (0.077) 0.983 1.004 [0.662 ~ 1.525]
G T G 190.00 (0.328) 117.00 (0.177) <0.001 2.261 [1.735 ~ 2.946]
T T G 69.00 (0.119) 160.00 (0.242) <0.001 0.422 [0.310 ~ 0.574]
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with a frequency of <0.03 were excluded. Statistical signifi-
cance was established at P <0.05.
Results
Characteristics of the study population
The baseline characteristics of the study population are
shown in Table 1. The primary source of infection was
the lungs, involving 91.1% of the combined sample of
sepsis alone and ALI patients. There was no significant
difference in age, gender, BMI, diabetes, liver cirrhosis
and history of smoking between ALI patients and sepsis
alone patients (P >0.05).
Associations of the ApoA1 gene SNPs with ALI risk
Table 2 shows the distribution of the genotypes and al-
leles of these 3 SNPs. The genotype distribution of each
SNP did not show significant difference from the Hardy-
Weinberg equilibrium values (data not shown). We found
rs11216153 polymorphism of ApoA1 was associated with
ALI, the GG genotype and G allele was common in the
ALI patients (76.9%, 88.1%, respectively) than both in the
control subjects (55.8%, 75.8%, respectively, P < 0.001) and
in the sepsis alone patients (58.2%, 78.4%, respectively,
P < 0.001). However, we did not find any association
of rs2070665 and rs632153 with ALI.
Associations of the ApoA1 gene haplotypes with ALI risk
As shown in Table 3 and Table 4, the frequency of haplo-
type GTG in the ALI samples was significantly higher than
that in the healthy control group (OR = 2.261, 95% CI:
1.735 ~ 2.946, P <0.001) and the sepsis alone group (OR =
1.789, 95% CI: 1.373 ~ 2.331.P < 0.001). Carriers of the
haplotype TTG had a lower risk for ALI compared with
healthy control group (OR = 0.422, 95% CI: 0.310 ~ 0.574,
P < 0.001) and sepsis alone group (OR = 0.491, 95% CI:
0.356 ~ 0.676, P <0.001).Table 4 Distribution of haplotypes (ALI patients vs. Sepsis alo
Haplotype ALI patients Sepsis alone
G C G 276.00 (0.476) 279.99 (0.491)
G C T 45.00 (0.078) 45.00 (0.079)
G T G 190.00 (0.328) 122.01 (0.214)
T T G 69.00 (0.119) 122.99 (0.216)Discussion
In the present study, we found ApoA1 gene polymor-
phisms and haplotypes were significant associated with
ALI risk in a Chinese population. Some studies have
been performed to find an association of genetic poly-
morphisms and ALI [20]. A prospective case–control
study found that -607C/C genotype in IL-18 gene played
a pivotal role in the development of ALI in Chinese Han
population [21]. Another case–control study found that
the IL-6 -572 polymorphism was associated with ALI
[22]. Several studies have suggested that pre-B-cell colo-
nyenhancing factor (PBEF) gene polymorphisms were as-
sociated with susceptibility and prognosis of ALI [23,24].
The plasminogen activator inhibitor-1 (PAI-1) 4G allele
was associated with worse outcome in ALI/ARDS [25]. A
prospective cohort demonstrated that the AC genotype at
position −1221 in the NQO1 gene caused decreased tran-
scription and was associated with a lower incidence of
ALI following major trauma [26]. In a nested case–control
study, patients with the NRF2 -617 A allele had a signifi-
cantly higher risk for developing ALI after major trauma
[27]. A case–control study found that myosin light chain
kinase (MYLK) genetic variants were associated with in-
creased risk of sepsis-associated ALI [28].
The ApoA1 gene has recently been linked to many other
diseases. A comparative study found that carrying the
ApoA1 -75 A allele could confer a higher risk of hyperlip-
idemia in obese children [29]. A prospective case–control
study found that the ApoA1 -75 G/A polymorphism in-
fluenced cholesterol metabolism [30]. A pilot study in a
north Indian population suggested that the ApoA1 -75 G
allele might be a susceptibility allele for myocardial
infarction [31].
In our study, we genotyped 3 SNPs in ApoA1 in Chinese
participants and assessed the association between ApoA1
and ALI using a haplotype-based case–control analysis.
The rs11216153 significantly differed between ALI pa-
tients and control participants, indicating that the risk
of ALI is increased in participants with the G allele
of rs11216153. Morris and Kaplan found that for
genes with multiple susceptibilities, analysis based on
haplotypes has advantages over analysis based on indi-
vidual SNPs [32]. Consequently, in the present study, we
successfully established haplotypes for the ApoA1 gene
from the different combination of the 3 SNPs. The fre-
quency of the GTG was associated with increased risk forne patients)
patients P OR (95% CI)
0.602 0.940 [0.746 ~ 1.185]
0.931 0.981 [0.638 ~ 1.509]
<0.001 1.789 [1.373 ~ 2.331]
<0.001 0.491 [0.356 ~ 0.676]
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risk for ALI.
Although we found rs11216153 was associated with
ALI risk in the present study, this SNP was located in
the non-coding region of ApoA1. Given that this SNP
was tag SNP, it is more likely that rs11216153 is tagging
other common or rare variants of the ApoA1 gene asso-
ciated with ALI. Another possibility is that the associ-
ation might be due to LD with variants from nearby
genes. Exhaustive resequencing is required to find or
rule out the possibility of an as-yet-unidentified causal
SNP in LD with rs11216153. And further functional
studies are needed to investigate whether the variants have
an effect on ApoA1 mRNA stability and translatability.
This study has a number of strengths. First, a sepsis
without ALI group was used for comparison to exclude
the possibility of a false association with sepsis. Second,
to minimize racial admixture, we focused on central
Han Chinese patients, which could be regarded as one
single homogenous population [23,24]. Third, to reduce
the heterogeneous etiologies for ALI, the present study
only included patients whose primary etiology for ALI
was sepsis.
Some limitations of this study should be noted. First
of all, these results should be interpreted with caution
because the population was only from China, which re-
duces the possibility of confounding from ethnicity, so it
does not permit extrapolation of the results to other eth-
nic groups. Second, the sample size of this study is rela-
tively small, which may not have enough statistical power
to explore the real association. Third, this is a hospital
based case–control study, so the selection bias cannot be
avoidable and the subjects may not be representative of
the general population.Conclusion
In conclusion, the present results indicate that ALI is as-
sociated with the ApoA1 gene polymorphisms. The GTG
haplotype appear to be a risk genetic marker and the
TTG haplotypes might be protective factor of ALI in
Chinese people.
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